Anrun Pharmaceutical is Drug Discovery in China that focus on drug synthesis process business. Founded in 2011. They cover business area such as developer, drug, anti, -tumor, cardiovascular, central nervous system, innovative discovery service, new clinical candidate identification, domestic and foreign enterprise, high-quality api, key intermediate.
2011
( 13 years old in 2024 )
Drug Synthesis Process
-
Sangtian, No. 1, Huayun Road
Suzhou Industrial Park Island Science and Technology Park Building 6
Suzhou, Zhejiang 215123
China
Private
developerdruganti-tumor, cardiovascular, central nervous systeminnovative discovery servicenew clinical candidate identificationdomestic and foreign enterprisehigh-quality apikey intermediate
* We use standard office opening hours in near Anrun Pharmaceutical's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Anrun Pharmaceutical is Drug Discovery business from China that founded in 2011 (13 years old in 2024), Anrun Pharmaceutical business is focusing on Drug Synthesis Process.
Anrun Pharmaceutical headquarter office and corporate office address is located in Sangtian, No. 1, Huayun Road Suzhou Industrial Park Island Science and Technology Park Building 6 Suzhou, Zhejiang 215123 China.
Anrun Pharmaceutical was founded in China.
In 2024, Anrun Pharmaceutical is currently focus on drug synthesis process sector.
Above is snippet of Google Trends for "drug synthesis process" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Anrun Pharmaceutical, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
